ONCOTECHNOLOGIES LTD - MORDEN
| Company Profile | Company Filings |
Overview
ONCOTECHNOLOGIES LTD is a Private Limited Company from MORDEN ENGLAND and has the status: Active.
ONCOTECHNOLOGIES LTD was incorporated 4 years ago on 22/01/2020 and has the registered number: 12418793. The accounts status is MICRO ENTITY and accounts are next due on 31/12/2024.
ONCOTECHNOLOGIES LTD was incorporated 4 years ago on 22/01/2020 and has the registered number: 12418793. The accounts status is MICRO ENTITY and accounts are next due on 31/12/2024.
ONCOTECHNOLOGIES LTD - MORDEN
This company is listed in the following categories:
86220 - Specialists medical practice activities
86220 - Specialists medical practice activities
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 3 | 31/03/2023 | 31/12/2024 |
Registered Office
12 LONDON ROAD
MORDEN
SM4 5BQ
ENGLAND
This Company Originates in : United Kingdom
Previous trading names include:
WILLIAMS CONSULTING (ONCOLOGY) LIMITED (until 04/08/2022)
WILLIAMS CONSULTING (ONCOLOGY) LIMITED (until 04/08/2022)
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 21/01/2023 | 04/02/2024 |
Map
ENGLAND
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| DR MATTHEW HARDY WILLIAMS | Dec 1974 | British | Director | 2020-01-22 | CURRENT |
| MRS BHANU WILLIAMS | Dec 1976 | British | Director | 2020-01-22 UNTIL 2022-08-08 | RESIGNED |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Mr Matthew Hardy Williams | 2020-01-22 | 12/1974 | Godalming |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| ONCOTECHNOLOGIES LTD - Filleted accounts | 2023-12-21 | 31-03-2023 | £231,388 equity |
| ONCOTECHNOLOGIES LTD - Filleted accounts | 2022-12-20 | 31-03-2022 | £130,940 equity |
| Williams Consulting (Oncology) Limited | 2021-10-23 | 31-03-2021 | £47,328 equity |